Who funds CAR-T cell therapy research?
We count 104 funded CAR-T cell therapy projects, active between 2020 and 2035, from 6 funders. The most came from EU · ERC (38 projects), EU · MSCA (14 projects) and EU · EIC (9 projects). The median award is $2.1M, across the 102 of 104 projects that list an amount.
- Funded projects
- 104
- Funders
- 6
- Median award
- $2.1M
- Open calls now
- 1
Top funders of CAR-T cell therapy research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| EU · ERC | 38 | 37% | $1.6M |
| EU · MSCA | 14 | 13% | $316K |
| EU · EIC | 9 | 9% | $2.6M |
| EU · Health | 6 | 6% | $8.8M |
| NSF · CISE | 6 | 6% | $637K |
| EU · Climate, Energy and Mobility | 5 | 5% | $8.6M |
| EU · Digital, Industry and Space | 5 | 5% | $8.9M |
| Wellcome | 4 | 4% | $1.6M |
| NIH · NCI | 3 | 3% | $3M |
| UKRI · EPSRC | 3 | 3% | — |
Projects whose title or summary mentions CAR-T cell therapy. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open CAR-T cell therapy funding calls
1 open call mentions CAR-T cell therapy today.
-
National Indian Health Outreach and Education
Indian Health Service$246,311 – $1,101,311Deadline: November 2, 2026 ·
Funded CAR-T cell therapy projects
A sample, latest start first, at most three per program.
-
Decoding adaptive-like γδ T-cell recognition in human herpesvirus infection
Wellcome · £4,000,000 · ends 2035
-
Development of next-generation CAR-T cells for enhanced efficacy and reduced toxicity in T-cell acute lymphoblastic leukaemia (T-ALL)
Wellcome · £1,283,786 · ends 2031
-
RI: Uncertainty Quantification for Robust Decision Making
NSF · CISE · $1,000,000 · ends 2030
-
FET: Neuro-Symbolic Reasoning for Verified Hardware-Software Co-Design
NSF · CISE · $800,000 · ends 2030
-
HEMATOPOIETIC STEM/PROGENITOR CELL BASED CAR THERAPY TARGETING HIV
NIH · NIAID · $3,149,992 · ends 2030
-
Immunoengineering Durable Control of HIV Replication
NIH · NIAID · $3,643,653 · ends 2030
-
Smart materials, processes and optical devices for immersive technologies
UKRI · EPSRC · £1,332,239 · ends 2029
-
Collaborative Research: VINES: Track 1: AI-Enhanced Reconfigurable and Scalable Terahertz CMOS Transceiver Panel for NextG Communication Systems via Multidimensional Integration
NSF · CISE · $367,857 · ends 2029
-
The Role of Neighborhood Social Exposome Dynamics in Risk and Resilience to Alzheimer's Disease and Related Dementias
NIH · NIA · $3,039,714 · ends 2029
-
Toward development of senolytic CAR T cells
NIH · NIA · $3,326,400 · ends 2029
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “car t or car-t”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with CAR-T cell therapy calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free